ICON plc
The Vendor Scoping Lead manages the end-to-end scoping, budgeting, and vendor selection process for clinical and non-clinical studies, ensuring accurate and competitive budgets are delivered on time. This role involves negotiating clinical trial budgets, collaborating with internal teams and service providers, and supporting study start-up and governance approvals. The position requires a strong background in drug development, vendor management, and financial analysis to optimize outsourcing strategies and maintain budget integrity.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
ICON plc didn’t post a salary, so this is our estimate from similar listings.
Director, Clinical Vendor Strategy (North America)
ErgoMed, Inc.
Director, Clinical Vendor Strategy (North America)
ErgoMed, Inc.
Clinical Contracts Manager
Isomorphic Labs
Trial Vendor Senior Manager
Parexel
Director, Clinical Vendor Strategy (North America)
ErgoMed, Inc.
Director, Clinical Vendor Strategy (North America)
ErgoMed, Inc.